FindTrial
Sign In

Effect of intravenous andcaudal ketamine on the EC50 andEC95 of ropivacaine for caudal block in young children

Effect of intravenous andcaudal ketamine on the EC50 andEC95 of ropivacaine for caudal block in young children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003491
Enrollment
Unknown
Registered
2013-08-13
Start date
2013-08-26
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inguinal hernia andhydrocele in children

Interventions

control group:caudal ropivacaine
group RKc:caudal ropivacaine and ketamine
group RKi:intravenous ketamine and caudal ropivacaine

Sponsors

Guangzhou Women andChildrens Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 3 Years

Inclusion criteria

Inclusion criteria: ASA grade I, II; children aged 1-3 years;children weighing 8-18kg; inguinal hernia andhydrocele in children

Exclusion criteria

Exclusion criteria: children were excluded if they have neurological, neuromuscular, psychiatrics, blood clotting disorders, or a known history of active andsevere renal, hepatic, respiratory of cardiac disease, or a known allergy to local anaesthetics

Design outcomes

Primary

MeasureTime frame
MLAC of ropivacain;—

Secondary

MeasureTime frame
duration of analgesia and adeverse event;—

Countries

China

Contacts

Public ContactSong Xing-Rong
songxr1966@yeah.net+86 13922416303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026